Doctor KE has been engaged in clinical, teaching, and research work in hematology for over 40 years, with particular expertise and high reputation in clinical and basic research on lymphoma. She has studied at the Hematology Research Center of Boston University Hospital and completed her postdoctoral fellowship in malignant hematologic diseases at the Dana-Farber Cancer Institute, Harvard Medical School.

She specializes in standardized treatment of lymphoma and comprehensive treatment of refractory and relapsed lymphoma. She has extensive experience in  precision targeted therapy guided by NGS, molecular biology diagnosis of lymphoma, monitoring of minimal residual disease, autologous peripheral blood stem cell transplantation, non-myeloablative transplantation, and cell immunotherapy for refractory and relapsed malignant lymphoma. and CAR-T cell immunotherapy.